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This association remained significant after adjusting for age, sex and baseline vessel size. 
When subjects were divided into three groups based on Lp(a) levels, FMD in highest group 
(n = 7) with Lp(a) > 120 m~VdL was significantly lower than that in the lowest group (n = 63) 
with Lp(a) < 60 mgJdL: (1.40 ± 2.14% vs 5.79 ± 4.29%, p < 0.05). No relationship was 
found between Lp(a) and NTG (r = 0.14, p = 0.34). In conclusion, these findings support an 
atherogenic role of I..p(a) in all ethnic groups, which is particularly evident in those who 
have extremely high levels. 
9:45 a.m. 
882-6 Age and Lipoprotein(s) Are Independent Predictors of 
Coronary but Not Aortic Arteriosclerosis on Electron 
Beam Tomogrsphy 
Paolo Raaoi. Gerald Friede, Donna Plourd, John L. Bayer, Tulane University School of 
Medicine, New Orleans, Louisiana. 
Background. Lp(a) might cause coronary and peripheral vascular disease. However, it is 
not clear whether Lp(a) contributes to coronary and aortic arteriosclerosis (ASC) inde- 
pendent of LDL-c. In fact, the ASC risk attributed to Lp(a) could be related to simulta- 
neously elevated LDL-c levels. Methods. 109 pts (78% males, mean age 54) undergoing 
evaluation for risk factors for ASC and screening for vascular calcification by electron 
beam tomography. 3mm scans for the coronary arteries and 6mm scans for the thoracic 
and abdominal aorta were performed on all pts. Volumetric calcium scores (CS) were cal- 
culated. Descriptive statistics and regression analyses to identify predictors of CS are 
reported. Results. The Lp(a) levels were similar in pts with LDL-c > or <130 mg/dl (22 vs 
18 mg/dl; p=NS). Additionally, the coronary and aortic CS's did not differ in pts with LDL> 
or <130 mg/dl. In contrast, coronary CS's were statistically greater in pts with Lp(a)>11 
mg/dl than </= 10mg/dl and even greater in pts with Lp(a)>20 mg/dl (90th percentile. See 
table). Aortic CS's were non significantly different at all levels of Lp(a). On multivariable 
analyses (considedng Lp(a), all conventional dsk factors for ASC and lipid levels) age 
(p<0.001) and Lp(a) (p<O.O0001) were independent predictors of coronary CS's while 
age was the only predictor of aortic CS. Conclusion. Lp(a) is a strong risk for coronary 
ASC independent of LDL. Neither conventional risk factors nor Lp(a) predict aortic ASC 
that appears to be an age related phenomenon 
Lipoprotein (a) level Coronary Ca-score Aorta Ca-Score 
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</=10m~dl 212+#329 1200+/-2290 
>11 mg/dl 541+/-674 1091+/-2905 
>20m~dl 638+/-754 1329+/-3394 
p<0.002forallcomparisons p=NS ~rancompadsons 
10:45 a.m. 
891-2 Influence of Hypertension on the Initial and Long-Term 
Outcome of Patients Treated With Coronary Stenting 
Joaeuin J, Alonso. Fededco Gimeno, Benigno Ramos, Juan M. Duran, Juan C. Munoz, 
Luis Fuente, Gemma Pastor, Itziar Gomez, Jose Bermejo, Francisco Femandez-Aviles, 
Instituto Ciencias del Corazon (ICICOR), Valladclid, Spain. 
Background: Hypertension (HT) is a well-established coronary risk factor but there are 
scant data regarding its influence on the initial evolution and above all on the long term 
outcome of coronary stenting (CS). 
Methods: The objective of the present study is to analyze in a cohort of 837 consecutive 
patients treated with CS between September 1993 and June 1997, the influence of 
hypertension on the initial and long-term evolution. Three hundred and thirty three had 
HT and 502 did not. The average duration of follow-up was 4,0±1,2 years (median: 3,4, 
range: 2-6,4 years). 
Results: Clinical initial success rate (angiographic success without major complications 
during the first month) among patients with and without HT (92,5 vs 95,2 %, P=0,10) and 
the incidence of angiographic restenosis after 6 months (28 vs 27%, P=0,72} were simi- 
lar. Mortality during follow-up was similar in both groups (HT: 9%, non-HT: 8%, P=0,63). 
Nevertheless the multivariate analysis (Cox regression) showed that the need for new 
revascularization procedures (both at stent level or over new lesions appeared during fol- 
low-up) in patients with HT was 20% higher (HR: 1,20; CI 95%: 1,01-1,41 ; P=O,03). The 
incidence of major adverse cardiac events during follow-up was also 14% higher (HR: 
1,14; CI 95%: 1,0t-1,29; P=0,03) in patients with HT. Revascutarization free survival at 5 
years (Kaplan-Meier) was 79% in non-HT pts and 75% in HT pts (leg-rank test: 0,02). 
Estimated survival without major adverse cardiac events at 5 years was 65% in non-HT 
and 55% in pts with HT (log-rank test: 0,03). 
Conclusion: Thus, 1) the initial and six-month clinical and angiographic results of coro- 
nary stenting were similar among patients with and without HT; 2) In the long-term, HT 
acts as an independent predictor of a worse clinical evolution (higher incidence of events 
and need for revascularization), probably due to the unfavorable effect of HT on the evo- 
lution of coronary disease. 
11:00 a.m. 
891-3 Elevated Pulse Pressure on Admission After Acute 
Myocardial Infarction Reduces Short- and Long-term 
All-Cause and Cardiac Mortality: An Analysis of 
Surv iva l  Trials 
Yee Guan Yao, Trinh Duong, Martin Bland, Marek Malik, Christian Torp-Pederson, Lars 
Kober, Bradley Marchant, A. John Carom, St. George's Hospital Medical School, London, 
United Kingdom. 
Background: We hypothesised that pulse pressure (PP) in patients after myocardial inf- 
arction (MI) carries a prognostic value. Methods: We pooled the placebo patient data 
from EMIAT, CAMIAT, SWORD, TRACE and DIAMOND-MI studies which recruited 
patients with LVEF <40% or frequent ventdcular ectopics after MI. The effect of admis- 
sion blood pressure and PP was investigated using Cox regression, adjusted for age, 
sex, previous MI, Q wave, hypertensive history, NYHA class, heart rate, LVEF, treatment 
and study effects. Survival analysis at 2 year was measured from day 45 after MI to allow 
for different recruitment periods, Short-term survival up to 45 days was also examined 
based on patients from TRACE and DIAMOND-MI that recruited patients within 2 weeks 
(logistic regression). Results: 3311 placebo patients were pooled (2512 M, age: 64, 23- 
92). 187 patients died within 45 days after MI (94 arrhythmic (AM) & 74 cardiac mortality 
(CM)). 3016 patients were followed-up from day 45 after MI to 2-year. 471 died by 2 
years (212 AM & 170 CM), PP, systolic (SBP) and diastolic (DBP) blood pressure all 
inversely associated with the risk of long-term (45 days - 2 years) all-cause (ACM) and 
AM but not CM. The association was stronger for short-term mortality (<45 d) (table). PP 
correlated strongly with SBP but not DBP (r= 0.80-0.91, p<0.0001). Conclusions: Our 
study showed that elevated PP, SBP or DBP on admission after acute MI paradoxically 
reduces ACM and AM although not CM. BP measurement after MI has significant prog- 
nostic value. 
Mortality 45d-2yr after MI ACM, Hazard Ratio (95% C.I.) AM, Hazard Ratio (98% C.I.) 
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891-1 The Influence of Hypertension on Management and 
Outcome of Acute Coronary Syndrome 
Silia K. Maiahalme. Dean E. Smith, Jeanna V. Cooper, Eva M. Kline-Regers, Yassar 
Almanaseer, Eyad Akhras, Rajendra H. Mehta, Kim A. Eagle, John D. Bisognano, 
University of Michigan Health Systems, Ann Arbor, Michigan. 
Background: Hypertension is a known risk factor for coronary artery disease. However, 
the influence of hypertension on the management and outcomes of patients with acute 
coronary syndromes(ACS) has not been previously described. 
Methods: We examined data from 1248 consecutive subjects admitted to the University 
of Michigan Health System (Ann Arbor, MI, USA) with diagnosis of ACS. Data were col- 
lected from April 1999 to December 2000 using a standardized form; 997 have 6-month 
follow-up data. 
Results: Hypertensives represented 64.6% (n=806) of this population. Compared to nor- 
motensive patients, they were older (55.8 vs 59.5 yrs, p=0,001), more often female 
(39.8% vs 26.5%, p<0.0001), and had more comorbidities such as previous myocardial 
infarction (49.4% vs 34.8%, p<0.0001), congestive heart failure (27.1% vs 14.0%, 
p<0.0001), and diabetes (36.4% vs 18.3%, p<0.0001). At admission, hypertensives had 
higher brood pressure (BP). Hypertensives presented more often with unstable angina 
(33.4% vs 25.1%, p=0,002) while normotensives had more acute myocardial infarction 
(AMI, 50.9% vs 42.8%, p=0.006). Among ACS patients, hypertensives with good BP con- 
trol had significantly less AMI than those with poor BP control. Hypertensives received 
more oral cardiovascular drugs, and had more frequent previous invasive procedures. 
There were no differences between hypertensives and normotensives at 6-month follow- 
up in deaths (9.3% vs 9.4%, p=0.97), acute myoacardial infarctions (10.8% vs 10.4%, 
p=0.89), but hypertensives were re-hospitalized more with cardiac problems (31.4% vs 
25.0%, p=O.04), 
Conclusion: Significant differences exist between hypertensives and normotensives in 
the presentation of ACS. Hypertensives had tess AMI than normotensives in our study 
and at 6-month follow-up, more hospitalizations due to cardiac problems were seen 
among hypertensives. This risk factor identifies a group of patients who may particularly 
benefit from more aggressive treatment and follow-up. 
PP, adjusted for DBP 0.97 (0.94-1.00), p=O.04 0.96 (0.92-1.00), p<0.05 
DBP 0.92 (0.86-0.98), p=O.O08 0.84 (0.77-0.92), p<O.O01 
SBP 0.91 (0.85-0.97), p=O.O02 0.84 (0.77-0.92), p<O.O01 
Mortality, <45d after MI 
PP, adjusted for DBP 0.93 (0.88-0.98), p=O.O07 0.91 (0.85-0.99), p=O.02 
DBP 0.87 (0.77-0.98), p=O.02 0.80 (0.68-0.93), p=O.O05 
SBP 0.80 (0.71-0.90), p<0.001 0.73 (0.61-0.86), p=0.001 
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11:15 a.m. 
Impaired Coronary Flow Reserve Determines Left 
Ventricular Diastolic Dysfunction in Arterial 
Hypertension 
Ziad Zeidan. Ya Yang, Thomas Bartel, 1"]co Ebralidze, Thomas Buck, Hoiger Eggebrecht, 
Raimund Ethel, Dept. of Cardiology, University Hospital Essen, Essen, Germany. 
Background: LV diastolic dysfunction (DD) in hypertension (HTN) represents the eady 
stage of LV functional impairment and has been particularly related to LV hypertrophy. 
DD was demonstrated in chronic coronary artery disease as welt, where hypertrophy has 
no rote in the pathophysiology. We therefore, hypothesized that impaired coronary flow 
